Although some MS therapeutics are attempting to tamp down the immune signals that lead to the loss of myelin, this study has tried another approach to repair myelin damage that has already happened.

Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

While many of these strategies are likely several years away from testing in the clinical domain, they provide insight into how the goals of MS therapeutics – halting and ultimately reversing ...

See Table 1 for currently approved disease-modifying MS therapeutics. Mathias Buttmann, MD, Julius-Maximilians University, Department of Neurology, Josef-Schneider-Str. 11, 97080 Würzburg ...

--(BUSINESS WIRE)--Progentos Therapeutics, a biotech company addressing the critical unmet need to regenerate myelin and restore function for patients with Multiple Sclerosis (MS) and other ...